Mouse Recombinant Monoclonal CP2c antibody. Carrier free. Suitable for IP, WB and reacts with Mouse, Rat, Human samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
IP | WB | ICC/IF | |
---|---|---|---|
Human | Tested | Tested | Not recommended |
Mouse | Tested | Tested | Not recommended |
Rat | Tested | Tested | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Select an associated product type
Binds a variety of cellular and viral promoters including fibrinogen, alpha-globin, SV40 and HIV-1 promoters. Activation of the alpha-globin promoter in erythroid cells is via synergistic interaction with UBP1 (By similarity). Functions as part of the SSP (stage selector protein) complex. Facilitates the interaction of the gamma-globin genes with enhancer elements contained in the locus control region in fetal erythroid cells. Interacts by binding to the stage selector element (SSE) in the proximal gamma-globin promoter.
LSF, SEF, TFCP2, Alpha-globin transcription factor CP2, SAA3 enhancer factor, Transcription factor LSF
Mouse Recombinant Monoclonal CP2c antibody. Carrier free. Suitable for IP, WB and reacts with Mouse, Rat, Human samples.
pH: 7.2 - 7.4
Constituents: 100% PBS
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
CP2c also known as LSF or TFCP2 functions as a transcription factor involved in the regulation of gene expression. CP2c has a mass of approximately 37 kDa. It is expressed in various tissues with higher levels observed in the liver brain and lymphoid tissues. This protein is critical in influencing the expression of genes through direct binding to specific DNA sequences thereby altering transcriptional activities.
CP2c serves as an important component in transcriptional regulation networks. It often functions as a part of multi-protein complexes interacting with co-activators or co-repressors to modulate target gene expression. CP2c plays significant roles in cell cycle control growth and differentiation by regulating genes involved in these biological processes.
CP2c integrates into key regulatory networks impacting several important pathways such as cell cycle and nucleotide metabolism. In the context of the cell cycle CP2c interacts with proteins such as p53 and Rb which are essential in controlling cell division and DNA repair processes. These interactions help maintain normal cellular function and prevent unchecked cell proliferation.
CP2c links to conditions like cancer and viral infections. Its regulation of genes involved in cell proliferation is important in oncogenesis where dysregulated CP2c activity may contribute to tumor progression. In viral infections CP2c modulates the host cellular environment affecting how viruses replicate within host cells. Aberrant interactions with proteins like p53 reinforce the connection between CP2c and the development of cancer emphasizing the importance of this protein as a target for therapeutic intervention.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-CP2c antibody [14/LSF] ab308611 the same antibody clone in a different buffer formulation.
CP2c was immunoprecipitated from 0.35 mg C6 (rat glial tumor glial cell) whole cell lysate 10 ug with Anti-CP2c antibody [14/LSF] ab308611 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using Anti-CP2c antibody [14/LSF] ab308611 at 1/1000 dilution. Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) was used at 1/10000 dilution.
Lane 1: C6 (rat glial tumor glial cell) whole cell lysate
Lane 2: Anti-CP2c antibody [14/LSF] ab308611 IP in C6 (rat glial tumor glial cell) whole cell lysate
Lane 3: Mouse monoclonal IgG (Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control ab18443) instead of Anti-CP2c antibody [14/LSF] ab308611 in C6 whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 59 seconds
All lanes: Immunoprecipitation - Anti-CP2c antibody [14/LSF] (Anti-CP2c antibody [14/LSF] ab308611) at 1/30 dilution
All lanes: C6 (rat glial tumor glial cell) whole cell lysate
All lanes: Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/10000 dilution
Exposure time: 59s
This data was developed using Anti-CP2c antibody [14/LSF] ab308611 the same antibody clone in a different buffer formulation.
CP2c was immunoprecipitated from 0.35 mg Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate 10 ug with Anti-CP2c antibody [14/LSF] ab308611 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using Anti-CP2c antibody [14/LSF] ab308611 at 1/1000 dilution. Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) was used at 1/10000 dilution.
Lane 1: Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate
Lane 2: Anti-CP2c antibody [14/LSF] ab308611 IP in Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate
Lane 3: Mouse monoclonal IgG (Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control ab18443) instead of Anti-CP2c antibody [14/LSF] ab308611 in Hepa1-6 whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 59 seconds
All lanes: Immunoprecipitation - Anti-CP2c antibody [14/LSF] (Anti-CP2c antibody [14/LSF] ab308611) at 1/30 dilution
All lanes: Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate
All lanes: Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/10000 dilution
Exposure time: 59s
This data was developed using Anti-CP2c antibody [14/LSF] ab308611, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration: 5% NFDM/TBST
Exposure time: Lanes 1-3: 37seconds, lane 4: 3 minutes Lanes 5-8: 48seconds
All lanes: Western blot - Anti-CP2c antibody [14/LSF] (Anti-CP2c antibody [14/LSF] ab308611) at 1/1000 dilution
Lane 1: THP-1 (human monocytic leukemia monocyte) whole cell lysate at 20 µg
Lane 2: HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3: K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg
Lane 4: Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate at 20 µg
Lane 5: Huh7 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 6: B16-F0 (mouse melanoma epithelial cell-like) whole cell lysate at 20 µg
Lane 7: C6 (rat glial tumor glial cell) whole cell lysate at 20 µg
Lane 8: NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
All lanes: Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) (ZB-2305) at 1/10000 dilution
Observed band size: 65 kDa
This data was developed using Anti-CP2c antibody [14/LSF] ab308611 the same antibody clone in a different buffer formulation.
CP2c was immunoprecipitated from 0.35 mg K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate 10 ug with Anti-CP2c antibody [14/LSF] ab308611 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using Anti-CP2c antibody [14/LSF] ab308611 at 1/1000 dilution. mouse IgG for IP (HRP) (Anti-mouse IgG for IP (HRP) ab131368) was used at 1/1000 dilution.
Lane 1: K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate
Lane 2: Anti-CP2c antibody [14/LSF] ab308611 IP in K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate
Lane 3: Mouse monoclonal IgG (Mouse IgG1, kappa monoclonal [MOPC-21] - isotype control ab18443) instead of Anti-CP2c antibody [14/LSF] ab308611 in K-562 whole cell lysate
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 24 seconds
All lanes: Immunoprecipitation - Anti-CP2c antibody [14/LSF] (Anti-CP2c antibody [14/LSF] ab308611) at 1/30 dilution
All lanes: K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate
All lanes: Immunoprecipitation - Anti-mouse IgG for IP (HRP) (Anti-mouse IgG for IP (HRP) ab131368) at 1/1000 dilution
Exposure time: 24s
This data was developed using Anti-CP2c antibody [14/LSF] ab308611, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration: 5% NFDM/TBST
Exposure time: 114 seconds
All lanes: Western blot - Anti-CP2c antibody [14/LSF] (Anti-CP2c antibody [14/LSF] ab308611) at 1/1000 dilution
Lane 1: Human heart tissue lysate at 20 µg
Lane 2: Human kidney tissue lysate at 20 µg
Lane 3: Rat heart tissue lysate at 20 µg
Lane 4: Rat kidney tissue lysate at 20 µg
All lanes: Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) (ZB-2305) at 1/10000 dilution
Observed band size: 65 kDa
Exposure time: 114s
This data was developed using Anti-CP2c antibody [14/LSF] ab308611, the same antibody clone in a different buffer formulation.Blocking and diluting buffer and concentration: 5% NFDM/TBST.
In Western blot, Anti-GAPDH antibody (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) loading control staining at 1/200000 dilution
Exposure time: 5.5 seconds
All lanes: Western blot - Anti-CP2c antibody [14/LSF] (Anti-CP2c antibody [14/LSF] ab308611) at 1/1000 dilution
Lane 1: 293T (human embryonic kidney epithelial cell) transfected with scrambled siRNA control whole cell lysate at 20 µg
Lane 2: 293T transfected with siRNA specifically targeting CP2c whole cell lysate at 20 µg
All lanes: Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) (ZB-2305) at 1/10000 dilution
Observed band size: 65 kDa
Exposure time: 5.5s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com